Literature DB >> 23910585

Relationship of myocardial fibrosis to left ventricular and mitochondrial function in nonischemic dilated cardiomyopathy--a comparison of focal and interstitial fibrosis.

Takashi Yamada1, Akihiro Hirashiki, Xian Wu Cheng, Takahiro Okumura, Shuzo Shimazu, Rie Okamoto, Norihiro Shinoda, Satoshi Isobe, Kyosuke Takeshita, Shinji Naganawa, Takahisa Kondo, Toyoaki Murohara.   

Abstract

BACKGROUND: Mitochondrial damage is associated with histologic myocardial fibrosis. Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) can be used to identify focal fibrosis. We examined whether myocardial fibrosis on CMR and collagen volume fraction (CVF) from biopsies correlated with left ventricular (LV) and mitochondrial function in patients with nonischemic dilated cardiomyopathy (DCM). METHODS AND
RESULTS: Fifty-nine DCM patients underwent CMR, cardiac catheterization, and endomyocardial biopsy. Minimum first derivative of LV pressure (LVdP/dt(min)) was measured as an index of LV relaxation. Mitochondrial RNA expression was also analyzed. For quantitative analysis of myocardial fibrosis, percentage LGE (%LGE) and CVF were calculated. Patients were divided into 2 groups on the basis of the presence (LGE group; n = 27) or absence (non-LGE group; n = 32) of LGE. Mean CVF and absolute value of LVdP/dt(min) were significantly higher and lower, respectively, in the LGE group than in the non-LGE group. Multivariate analysis revealed that %LGE was an independent determinant of LVdP/dt(min). The abundance of mitochondrial enzyme mRNA was significantly lower in the LGE group.
CONCLUSIONS: Noninvasive CMR imaging is more useful in predicting diastolic dysfunction than invasive histologic assessments. In addition, it might indicate mitochondrial dysfunction in DCM.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; diastolic function; magnetic resonance imaging; mitochondria

Mesh:

Year:  2013        PMID: 23910585     DOI: 10.1016/j.cardfail.2013.05.018

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  5 in total

1.  Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.

Authors:  Tomoaki Uemura; Megumi Yamamuro; Koichi Kaikita; Seiji Takashio; Daisuke Utsunomiya; Kyoko Hirakawa; Mina Nakayama; Kenji Sakamoto; Eiichiro Yamamoto; Kenichi Tsujita; Sunao Kojima; Seiji Hokimoto; Yasuyuki Yamashita; Hisao Ogawa
Journal:  Heart Vessels       Date:  2016-02-18       Impact factor: 2.037

2.  PDK4 Deficiency Induces Intrinsic Apoptosis in Response to Starvation in Fibroblasts from Doberman Pinschers with Dilated Cardiomyopathy.

Authors:  Kathryn Taggart; Amara Estrada; Patrick Thompson; Francisco Lourenco; Sara Kirmani; Silveli Suzuki-Hatano; Christina A Pacak
Journal:  Biores Open Access       Date:  2017-12-01

3.  High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Kenshi Hayashi; Noboru Fujino; Yoji Nagata; Akihiko Hodatsu; Eiichi Masuta; Kenji Sakata; Hiroyuki Nakamura; Masa-aki Kawashiri; Masakazu Yamagishi
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

4.  Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.

Authors:  Meijuan Zou; Fang Wang; Rui Gao; Jingjing Wu; Yingwei Ou; Xuguan Chen; Tongshan Wang; Xin Zhou; Wei Zhu; Ping Li; Lian-Wen Qi; Ting Jiang; Weiwei Wang; Chunyu Li; Jun Chen; Qifang He; Yan Chen
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

5.  An uncommon clinical presentation of relapsing dilated cardiomyopathy with identification of sequence variations in MYNPC3, KCNH2 and mitochondrial tRNA cysteine.

Authors:  Maria J Guillen Sacoto; Kimberly A Chapman; Deneen Heath; Mary Beth Seprish; Dina J Zand
Journal:  Mol Genet Metab Rep       Date:  2015-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.